User:Tkadm30/Notebook/Cannabidiol: Difference between revisions

Latest revision as of 14:58, 2 October 2018

CBD: a novel PPAR agonist to decrease neuroinflammation and promote hippocampal neurogenesis.[1]
Antioxidant activity of CBD/THC prevent glutamate induced neurotoxicity. [2][3]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/
[Paper1]
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20965/
[Paper2]
Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
https://www.ncbi.nlm.nih.gov/pubmed/10863546
[Paper3]
Neuroprotective antioxidants from marijuana.

@@ Line 1: / Line 1: @@
-Therapeutic use:
+==Therapeutic use of CBD==
-* CBD as anxiolytic drug: http://www.ncbi.nlm.nih.gov/pubmed/22729452
+===Neuroprotective properties of CBD===
-* CBD as antipsychotic drug: http://www.nature.com/tp/journal/v2/n3/full/tp201215a.html
+* CBD: a novel PPAR agonist to decrease neuroinflammation and promote hippocampal neurogenesis.<cite>Paper1</cite>
-Research:
+* Antioxidant activity of CBD/THC prevent glutamate induced neurotoxicity. <cite>Paper2</cite><cite>Paper3</cite>
-* CBD for epilepsy: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189631/
+==Notes==
+* CBD is a competitive CYP2D6 inhibitor
+== References ==
+<biblio>
+#Paper1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/
+//Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
+#Paper2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC20965/
+//Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidants
+#Paper3 https://www.ncbi.nlm.nih.gov/pubmed/10863546
+//Neuroprotective antioxidants from marijuana.
+</biblio>
+== See also ==
+* http://www.iqm.csic.es/paginas/cannabinoides%20y%20ppar/neuroinflammation.html
+* http://en.wikipedia.org/wiki/Cannabidiol